1. Academic Validation
  2. ZMPSTE24 defends against influenza and other pathogenic viruses

ZMPSTE24 defends against influenza and other pathogenic viruses

  • J Exp Med. 2017 Apr 3;214(4):919-929. doi: 10.1084/jem.20161270.
Bishi Fu 1 Lingyan Wang 2 Shitao Li 3 Martin E Dorf 4
Affiliations

Affiliations

  • 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
  • 2 Department of Physiological Sciences, Oklahoma State University, Stillwater, OK 74078.
  • 3 Department of Physiological Sciences, Oklahoma State University, Stillwater, OK 74078 dorf@hms.harvard.edu shitao.li@okstate.edu.
  • 4 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115 dorf@hms.harvard.edu shitao.li@okstate.edu.
Abstract

Zinc metallopeptidase STE24 (ZMPSTE24) is a transmembrane metalloprotease whose catalytic activity is critical for processing lamin A on the inner nuclear membrane and clearing clogged translocons on the endoplasmic reticulum. We now report ZMPSTE24 is a virus-specific effector that restricts enveloped RNA and DNA viruses, including influenza A, Zika, Ebola, Sindbis, vesicular stomatitis, cowpox, and vaccinia, but not murine leukemia or adenovirus. ZMPSTE24-mediated Antiviral action is independent of protease activity. Coimmunoprecipitation studies indicate ZMPSTE24 can complex with proteins of the interferon-induced transmembrane protein (IFITM) family. IFITM proteins impede viral entry, and ZMPSTE24 expression is necessary for IFITM Antiviral activity. In vivo studies demonstrate ZMPSTE24-deficient mice display higher viral burdens, enhanced cytokine production, and increased mortality after influenza Infection. Collectively, these findings identify ZMPSTE24 as an intrinsic broad-spectrum Antiviral protein and provide insights into Antiviral defense mechanisms.

Figures